Clinical Trial Information
Exceptional Safety and Efficacy
Effective Drug and Polymer Combination
- Powerful neointimal suppressor
- Low drug load
- 100% drug elution in 120 days*
PLATINUM Clinical Trial Program
- Numerically lower event rates at 4 years**
- Significantly less vessel straightening†
- Significantly less bail out stentingⱡ
- Significantly less incomplete stent apposition§
Workhorse Trial: 4-Year Results
- Relative Risk Reduction (ID-TLR)
- Continued Low Event Rates at 4 Years
Small Vessel Trial: 2-Year Results
- 0.0% ARC ST (Def/Prob)
- 0.0% MI
- 2.5% ID-TLR
Long Lesion Trial: 2-Year Results
- 0% ARC ST (Def/Prob)
- 0% TV-MI
QCA Study
- 83% Reduction in Post Procedure Incomplete Stent Apposition
- 0% Late Incomplete Stent Apposition